About
Small molecule for hearing disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
27
By Phase
PHASE2: 2
By Status
TERMINATED: 2WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04774250Collaborator
Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
PHASE2Terminated
3 participants
Started: Nov 10, 2021 · Completed: Dec 23, 2022
NCT04768569Collaborator
Noise-Induced Hearing Loss-Acute Exposure Treatment
PHASE2Terminated
24 participants
Started: Oct 4, 2021 · Completed: Sep 29, 2023
NCT04322747Lead Sponsor
Hearing Changes After Surgery
N/AWithdrawn
Started: Sep 1, 2021 · Completed: Feb 28, 2022
Funding History (1)
D
Jun 5, 2025
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...